jpmorgan chase & co. - JPM

JPM

Close Chg Chg %
310.01 12.34 3.98%

Closed Market

322.35

+12.34 (3.98%)

Volume: 17.80M

Last Updated:

Feb 6, 2026, 3:59 PM EDT

Company Overview: jpmorgan chase & co. - JPM

JPM Key Data

Open

$314.71

Day Range

314.71 - 324.25

52 Week Range

202.16 - 337.25

Market Cap

$863.69B

Shares Outstanding

2.72B

Public Float

2.71B

Beta

1.07

Rev. Per Employee

N/A

P/E Ratio

15.49

EPS

$20.05

Yield

187.00%

Dividend

$1.50

EX-DIVIDEND DATE

Jan 6, 2026

SHORT INTEREST

N/A

AVERAGE VOLUME

12.57M

 

JPM Performance

1 Week
 
5.40%
 
1 Month
 
-2.06%
 
3 Months
 
2.61%
 
1 Year
 
16.90%
 
5 Years
 
133.66%
 

JPM Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 30
Full Ratings ➔

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 349.958
Number of Ratings 30 Current Quarters Estimate 5.254
FY Report Date 03 / 2026 Current Year's Estimate 21.332
Last Quarter’s Earnings 4.63 Median PE on CY Estimate N/A
Year Ago Earnings 20.02 Next Fiscal Year Estimate 23.133
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 20 20 26 25
Mean Estimate 5.25 5.31 21.33 23.13
High Estimates 5.88 5.84 22.74 24.51
Low Estimate 5.01 5.15 20.48 22.19
Coefficient of Variance 3.78 3.20 2.26 2.82

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 13 13 12
OVERWEIGHT 6 6 4
HOLD 11 9 8
UNDERWEIGHT 0 1 3
SELL 0 1 1
MEAN Overweight Overweight Overweight

Insider Actions for Jpmorgan Chase & Co. - JPM

Date Name Shares Transaction Value
Jan 23, 2026 Mary Callahan Erdoes CEO Asset & Wealth Management 29,364 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 23, 2026 Douglas B. Petno Co-CEO CIB 25,938 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 23, 2026 Stacey Friedman General Counsel 18,108 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 23, 2026 Douglas B. Petno Co-CEO CIB 368,315 Bona fide gift 0.00
Jan 23, 2026 Jennifer A. Piepszak Chief Operating Officer 21,289 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 23, 2026 Alicia S. Boler-Davis Director 3,611 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $306.5 per share 1,106,771.50
Jan 23, 2026 Ashley Bacon Chief Risk Officer 18,108 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 23, 2026 Lori A. Beer Chief Information Officer 12,725 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 23, 2026 Alex Gorsky Director 7,294 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $306.5 per share 2,235,611.00
Jan 23, 2026 Phebe N. Novakovic Director 13,259 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $306.5 per share 4,063,883.50
Jan 23, 2026 Robin Leopold Head of Human Resources 8,565 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 23, 2026 Jeremy Barnum Chief Financial Officer 18,108 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 23, 2026 Troy Rohrbaugh Co-CEO CIB 25,938 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 23, 2026 Mark Alan Weinberger Director 4,111 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $306.5 per share 1,260,021.50
Jan 23, 2026 Marianne Lake CEO CCB 21,534 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 23, 2026 Virginia M. Rometty Director 14,700 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $306.5 per share 4,505,550.00
Jan 23, 2026 Michele G. Buck Director 919 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $306.5 per share 281,673.50
Jan 23, 2026 Brad D. Smith Director 2,947 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $306.5 per share 903,255.50
Jan 16, 2026 Troy Rohrbaugh Co-CEO CIB 20,082 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jan 16, 2026 Marianne Lake CEO CCB 97,322 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00

Jpmorgan Chase & Co. in the News